Discordant MRI/FDG-PET imaging for the diagnosis of borderline ovarian tumors

D. C. Jung; H. J. Choi; W. Ju; S. C. Kim; K. G. Choi

doi:10.1111/j.1525-1438.2007.01116.x

Discordant MRI/FDG-PET imaging for the diagnosis of borderline ovarian tumors

D. C. Jung, H. J. Choi, W. Ju, S. C. Kim, K. G. Choi

Department of Obstetrics and Gynecology

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Abstract

The objective of this study was to assess the role of ¹⁸F- fluorodeoxyglucose positron emission tomography (FDG-PET) for the characterization of ovarian masses that were diagnosed as ovarian malignancies by magnetic resonance imaging (MRI). We performed a retrospective review of eight patients with pathologically confirmed borderline ovarian tumors (BOT) who underwent MRI and FDG-PET before surgical staging from August 2005 to March 2007. We assessed the PET imaging of the BOT, measured the FDG uptake and quantified the findings as a standardized uptake value (SUV). The FDG-PET scans, of all eight patients, showed uptake of FDG with a mean SUV of less than 2.0 in the solid portion of the masses evaluated. We conclude that the MRI-PET differences may help differentiate borderline from malignant ovarian tumors.

Original language	English
Pages (from-to)	637-641
Number of pages	5
Journal	International Journal of Gynecological Cancer
Volume	18
Issue number	4
DOIs	https://doi.org/10.1111/j.1525-1438.2007.01116.x
State	Published - Jul 2008

Keywords

Borderline ovarian tumor
MRI
PET

Access to Document

10.1111/j.1525-1438.2007.01116.x

Cite this

@article{ea0fc08b0b40453faceef431cad1451d,

title = "Discordant MRI/FDG-PET imaging for the diagnosis of borderline ovarian tumors",

abstract = "The objective of this study was to assess the role of 18F- fluorodeoxyglucose positron emission tomography (FDG-PET) for the characterization of ovarian masses that were diagnosed as ovarian malignancies by magnetic resonance imaging (MRI). We performed a retrospective review of eight patients with pathologically confirmed borderline ovarian tumors (BOT) who underwent MRI and FDG-PET before surgical staging from August 2005 to March 2007. We assessed the PET imaging of the BOT, measured the FDG uptake and quantified the findings as a standardized uptake value (SUV). The FDG-PET scans, of all eight patients, showed uptake of FDG with a mean SUV of less than 2.0 in the solid portion of the masses evaluated. We conclude that the MRI-PET differences may help differentiate borderline from malignant ovarian tumors.",

keywords = "Borderline ovarian tumor, MRI, PET",

author = "Jung, {D. C.} and Choi, {H. J.} and W. Ju and Kim, {S. C.} and Choi, {K. G.}",

year = "2008",

month = jul,

doi = "10.1111/j.1525-1438.2007.01116.x",

language = "English",

volume = "18",

pages = "637--641",

journal = "International Journal of Gynecological Cancer",

issn = "1048-891X",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Discordant MRI/FDG-PET imaging for the diagnosis of borderline ovarian tumors

AU - Jung, D. C.

AU - Choi, H. J.

AU - Ju, W.

AU - Kim, S. C.

AU - Choi, K. G.

PY - 2008/7

Y1 - 2008/7

N2 - The objective of this study was to assess the role of 18F- fluorodeoxyglucose positron emission tomography (FDG-PET) for the characterization of ovarian masses that were diagnosed as ovarian malignancies by magnetic resonance imaging (MRI). We performed a retrospective review of eight patients with pathologically confirmed borderline ovarian tumors (BOT) who underwent MRI and FDG-PET before surgical staging from August 2005 to March 2007. We assessed the PET imaging of the BOT, measured the FDG uptake and quantified the findings as a standardized uptake value (SUV). The FDG-PET scans, of all eight patients, showed uptake of FDG with a mean SUV of less than 2.0 in the solid portion of the masses evaluated. We conclude that the MRI-PET differences may help differentiate borderline from malignant ovarian tumors.

AB - The objective of this study was to assess the role of 18F- fluorodeoxyglucose positron emission tomography (FDG-PET) for the characterization of ovarian masses that were diagnosed as ovarian malignancies by magnetic resonance imaging (MRI). We performed a retrospective review of eight patients with pathologically confirmed borderline ovarian tumors (BOT) who underwent MRI and FDG-PET before surgical staging from August 2005 to March 2007. We assessed the PET imaging of the BOT, measured the FDG uptake and quantified the findings as a standardized uptake value (SUV). The FDG-PET scans, of all eight patients, showed uptake of FDG with a mean SUV of less than 2.0 in the solid portion of the masses evaluated. We conclude that the MRI-PET differences may help differentiate borderline from malignant ovarian tumors.

KW - Borderline ovarian tumor

KW - MRI

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=47649124498&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1438.2007.01116.x

DO - 10.1111/j.1525-1438.2007.01116.x

M3 - Article

C2 - 17944914

AN - SCOPUS:47649124498

SN - 1048-891X

VL - 18

SP - 637

EP - 641

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

IS - 4

ER -

Discordant MRI/FDG-PET imaging for the diagnosis of borderline ovarian tumors

Abstract

Keywords

Access to Document

Fingerprint

Cite this